Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02296944
Other study ID # 1798756
Secondary ID
Status Completed
Phase N/A
First received October 22, 2014
Last updated December 20, 2017
Start date January 6, 2015
Est. completion date December 8, 2017

Study information

Verified date December 2017
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is a retrospective cohort of patients minors during the operation of cartilage tympanoplasty for tympanic membrane perforation


Description:

The investigators hypothesis is that the cartilage tympanoplastie lead to a closure of the tympanic membrane in 95% of cases. But the investigators believe that certain risk factors may influence the anatomical and functional results of tympanoplastie of the child and that their inclusion could improve these results.

For example, young age is not clear so far as a potential risk factor in the few studies analyzing this factor independently. A recommendation of the French Society of ENT surgery tympanic membrane perforation of the Child in 2006 recommended a minimum age of 6 years. However, the level of evidence of articles analyzed was small (it was basically a consensus of experts) and the investigators feel it necessary to study this factor by age (<7 years, 7-10 years, 11-14 years ,> 14 years) on a large cohort to determine the real influence of age on the anatomical and functional results as this may lead to changes in practice.

Similarly, whatever the influence of age in the general population, it could be a key criterion in children who have a particular field leading to prolonged tubal dysfunction (vélopalatines slots and craniofacial malformations), leading to raising the age of surgery tympanic closure: the investigators have for example in 1000 tympanoplasties for perforation, expected recruitment numbers in this study, 50 patients with craniofacial malformation or vélopalatine slot.

The purpose of this study is to investigate the factors influencing the anatomic outcome at one year of cartilage tympanoplastie child.


Recruitment information / eligibility

Status Completed
Enrollment 980
Est. completion date December 8, 2017
Est. primary completion date December 8, 2017
Accepts healthy volunteers No
Gender All
Age group 3 Years to 35 Years
Eligibility Inclusion Criteria:

- Patient minors during the operation of cartilage tympanoplasty for tympanic membrane perforation (tympanoplasty for this first ear)

- Patient operated between early 1998 and late 2012

- Postoperative audiometry and otoscopy available between 9 and 18 months after surgery

Exclusion Criteria:

- History of tympanoplasty ipsilateral, tympanic membrane perforation associated with épidermose or cholesteatoma

- The holders of the parent or the patient has reached majority informed the doctor of their refusal to data collection.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Collection of anatomical and functional results in the appearance of the tympanic membrane after surgery


Locations

Country Name City State
France Hospital Necker - Enfants Malades Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary anatomical result of the appearance of the tympanoplasty (tympanic membrane perforation after surgery) Closed eardrum
Abnormal eardrum perforation residual, ear effusion, progressive retraction cholesteatoma
12 months (range 9 to 18 months)
Secondary Factors influencing the functional outcome of the tympanoplasty mean bone conduction (BC)
air conduction (AC)
residual air-bone gap (RR = AC-BC). AC, BC and RR means are calculated on an average of four frequencies 0.5, 1, 2, 4 kHz Good functional outcome will be determined by an average RR =20 dB. A labyrinthisation be defined by a mean post-op compounded BC over 10 dB or moypostop BC - BC moypréop> 10 dB.
12 months (range 9 to 18 months)
Secondary Factors influencing the functional outcome of the tympanoplasty mean bone conduction (BC)
air conduction (AC)
residual air-bone gap (RR = AC-BC). AC, BC and RR means are calculated on an average of four frequencies 0.5, 1, 2, 4 kHz Good functional outcome will be determined by an average RR =20 dB. A labyrinthisation be defined by a mean post-op compounded BC over 10 dB or moypostop BC - BC moypréop> 10 dB.
36 months ( range 30 to 42 months)
Secondary Change anatomical result of the tympanoplasty 36 months ( range 30 to 42 months)
Secondary factors affecting the anatomical and functional results of the tympanoplasty. clinical examination by pediatric ENT
hearing test
36 months ( range 30 to 42 months)
See also
  Status Clinical Trial Phase
Recruiting NCT04635228 - Biodesign® Otologic Repair Graft
Active, not recruiting NCT00222417 - Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease Phase 2/Phase 3
Recruiting NCT05086718 - Composite Cartilage Perichondrium Graft for Air Bone Gap Closure in Chronic Suppurative Otitis Media (CSOM) Without Posterior Meatal Flap N/A
Withdrawn NCT03904316 - Use of Biodesign® Otologic Graft in Tympanoplasty Phase 4
Completed NCT02307916 - Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations Phase 2
Terminated NCT01766856 - Eustachian Tube Function and Myringoplasty/Tympanoplasty N/A
Recruiting NCT06260618 - Effect of Chitodex Gel in Tympanoplasty Surgery N/A
Recruiting NCT04960384 - Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations Phase 2
Recruiting NCT03837665 - Efficacy of Platelet Enriched Plasma in Preventing Surgery for Patients With Chronic Tympanic Membrane Perforation Phase 1/Phase 2
Not yet recruiting NCT06257602 - Microscopic Versus Endoscopic Tympanoplasty
Completed NCT02550314 - A Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18 Phase 3
Not yet recruiting NCT00310349 - PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease Phase 3
Not yet recruiting NCT03416725 - Evaluation of Prognostic Factors in Tympanoplasty N/A
Not yet recruiting NCT04428463 - Repair of Tympanic Membrane Perforation Using Tachosil Under Local Anesthesia N/A
Completed NCT00714064 - PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers Phase 3
Completed NCT05605262 - Effects of 100% Medical Grade Manuka Honey on Tympanic Membrane Reconstruction Healing. Phase 2/Phase 3
Recruiting NCT05849844 - Tympanoseal Clinical Study N/A
Not yet recruiting NCT04687995 - Tragal Perichondrium Versus Pretragal Fascial (SMAS) Graft for Endoscopic Myringoplasty N/A
Completed NCT02120651 - Fibrin Monomer Compared With Hemostatic Sponge in the Integrity of the Graft During Tympanoplasty Phase 3
Withdrawn NCT03028272 - Hearing Results and Post Surgical Outcomes Using Amniotic Membrane Allograft vs. Fascia for Tympanoplasty N/A